- Home
- ATGL vs ATAI Comparison
ATGL vs ATAI Comparison
Compare ATGL & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATGL
- ATAI
- Stock Information
- Founded
- ATGL 2017
- ATAI 2018
- Country
- ATGL Hong Kong
- ATAI Germany
- Employees
- ATGL N/A
- ATAI N/A
- Industry
- ATGL
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- ATGL
- ATAI Health Care
- Exchange
- ATGL Nasdaq
- ATAI Nasdaq
- Market Cap
- ATGL 407.0M
- ATAI 444.7M
- IPO Year
- ATGL 2023
- ATAI 2021
- Fundamental
- Price
- ATGL $24.00
- ATAI $2.48
- Analyst Decision
- ATGL
- ATAI Strong Buy
- Analyst Count
- ATGL 0
- ATAI 3
- Target Price
- ATGL N/A
- ATAI $10.50
- AVG Volume (30 Days)
- ATGL 3.4K
- ATAI 2.7M
- Earning Date
- ATGL 12-31-2024
- ATAI 08-12-2025
- Dividend Yield
- ATGL N/A
- ATAI N/A
- EPS Growth
- ATGL N/A
- ATAI N/A
- EPS
- ATGL N/A
- ATAI N/A
- Revenue
- ATGL $1,590,148.00
- ATAI $1,863,000.00
- Revenue This Year
- ATGL N/A
- ATAI $554.22
- Revenue Next Year
- ATGL N/A
- ATAI N/A
- P/E Ratio
- ATGL N/A
- ATAI N/A
- Revenue Growth
- ATGL 42.17
- ATAI 572.56
- 52 Week Low
- ATGL $1.15
- ATAI $1.03
- 52 Week High
- ATGL $57.32
- ATAI $2.64
- Technical
- Relative Strength Index (RSI)
- ATGL 37.63
- ATAI 66.50
- Support Level
- ATGL $24.88
- ATAI $2.06
- Resistance Level
- ATGL $27.05
- ATAI $2.55
- Average True Range (ATR)
- ATGL 0.48
- ATAI 0.20
- MACD
- ATGL -0.12
- ATAI -0.02
- Stochastic Oscillator
- ATGL 0.00
- ATAI 72.41
About ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.